关注
Paul A. VanderLaan MD, PhD
Paul A. VanderLaan MD, PhD
Director of Surgical Pathology and Cytopathology - BIDMC, Associate Professor of Pathology - Harvard
在 bidmc.harvard.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators
PA VanderLaan, CA Reardon, GS Getz
Arteriosclerosis, thrombosis, and vascular biology 24 (1), 12-22, 2004
8322004
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
MJ Niederst, LV Sequist, JT Poirier, CH Mermel, EL Lockerman, ...
Nature communications 6 (1), 6377, 2015
5862015
Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers
D Rangachari, N Yamaguchi, PA VanderLaan, E Folch, A Mahadevan, ...
Lung cancer 88 (1), 108-111, 2015
4742015
Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach?
PA VanderLaan, E Marqusee, JF Krane
American Journal of Clinical Pathology 135 (5), 770-775, 2011
2512011
Mammary analogue secretory carcinoma: update on a new diagnosis of salivary gland malignancy
R Sethi, E Kozin, A Remenschneider, J Meier, P VanderLaan, W Faquin, ...
The Laryngoscope 124 (1), 188-195, 2014
1782014
Mutations in TP53, PIK3CA, PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomes
PA VanderLaan, D Rangachari, SM Mockus, V Spotlow, HV Reddi, ...
Lung cancer 106, 17-21, 2017
1772017
Thematic review series: The Immune System and Atherogenesis. The unusual suspects: an overview ofthe minor leukocyte populations in atherosclerosis
PA VanderLaan, CA Reardon
Journal of lipid research 46 (5), 829-838, 2005
1632005
Success and failure rates of tumor genotyping techniques in routine pathological samples with non-small-cell lung cancer
PA VanderLaan, N Yamaguchi, E Folch, DH Boucher, MS Kent, ...
Lung cancer 84 (1), 39-44, 2014
1622014
Correlation between classic driver oncogene mutations in EGFR, ALK, or ROS1 and 22C3–PD-L1≥ 50% expression in lung adenocarcinoma
D Rangachari, PA VanderLaan, M Shea, X Le, MS Huberman, ...
Journal of thoracic oncology 12 (5), 878-883, 2017
1452017
The atypia of undetermined significance/follicular lesion of undetermined significance: malignant ratio: a proposed performance measure for reporting in The Bethesda System for …
JF Krane, PA VanderLaan, WC Faquin, AA Renshaw
Cancer Cytopathology 120 (2), 111-116, 2012
1452012
The 2023 Bethesda System for Reporting Thyroid Cytopathology
S Ali, Z Baloch, B Cochand-Priollet, F Schmitt, V Philippe, P VanderLaan
Thyroid 33 (9), 1039-1044, 2023
1402023
Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significance
PA VanderLaan, E Marqusee, JF Krane
American journal of clinical pathology 136 (4), 572-577, 2011
1222011
Endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA): An overview and update for the cytopathologist
PA VanderLaan, HH Wang, A Majid, E Folch
Cancer cytopathology 122 (8), 561-576, 2014
1102014
Collection and handling of thoracic small biopsy and cytology specimens for ancillary studies: guideline from the college of American pathologists in collaboration with the …
S Roy-Chowdhuri, S Dacic, M Ghofrani, PB Illei, LJ Layfield, C Lee, ...
Archives of pathology & laboratory medicine 144 (8), 933-958, 2020
1012020
Safety and efficacy of PD-1 inhibitors among HIV-positive patients with non–small cell lung cancer
L Ostios-Garcia, J Faig, GC Leonardi, AE Adeni, SJ Subegdjo, CA Lydon, ...
Journal of Thoracic Oncology 13 (7), 1037-1042, 2018
922018
Responses to the multitargeted MET/ALK/ROS1 inhibitor crizotinib and co-occurring mutations in lung adenocarcinomas with MET amplification or MET exon 14 skipping mutation
SE Jorge, S Schulman, JA Freed, PA VanderLaan, D Rangachari, ...
Lung cancer 90 (3), 369-374, 2015
902015
Fine‐needle aspiration and core needle biopsy: an update on 2 common minimally invasive tissue sampling modalities
PA VanderLaan
Cancer cytopathology 124 (12), 862-870, 2016
892016
Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis
PA VanderLaan, CA Reardon, Y Sagiv, L Blachowicz, J Lukens, ...
The American journal of pathology 170 (3), 1100-1107, 2007
892007
Lung adenocarcinoma manifesting as pure ground-glass nodules: correlating CT size, volume, density, and roundness with histopathologic invasion and size
BH Heidinger, KR Anderson, U Nemec, DB Costa, SP Gangadharan, ...
Journal of Thoracic Oncology 12 (8), 1288-1298, 2017
852017
Adequacy of lymph node transbronchial needle aspirates using convex probe endobronchial ultrasound for multiple tumor genotyping techniques in non–small-cell lung cancer
E Folch, N Yamaguchi, PA VanderLaan, ON Kocher, DH Boucher, ...
Journal of Thoracic Oncology 8 (11), 1438-1444, 2013
802013
系统目前无法执行此操作,请稍后再试。
文章 1–20